J
Joellen Klaustermeier
Publications - 16
Citations - 1286
Joellen Klaustermeier is an academic researcher. The author has contributed to research in topics: Cervical cancer & HPV vaccines. The author has an hindex of 14, co-authored 16 publications receiving 1120 citations.
Papers
More filters
Journal ArticleDOI
Human papillomavirus DNA prevalence and type distribution in anal carcinomas worldwide.
Laia Alemany,Maëlle Saunier,Isabel Alvarado-Cabrero,Beatriz Quirós,Jorge Salmerón,Hai-Rim Shin,Edyta C. Pirog,Núria Guimerà,Gustavo Hernández-Suárez,Ana Félix,Omar Clavero,Belen Lloveras,Elena Kasamatsu,Marc T. Goodman,Marc T. Goodman,Brenda Y. Hernandez,Jan Laco,Leopoldo Tinoco,D.T. Geraets,Charles F. Lynch,Václav Mandys,Mario Poljak,Robert Jach,Josep Verge,Christine Clavel,Cathy Ndiaye,Joellen Klaustermeier,Antonio L. Cubilla,Xavier Castellsagué,Ignacio G. Bravo,Michael Pawlita,William G. Quint,Nubia Muñoz,Francesc Bosch,Silvia de Sanjosé +34 more
TL;DR: In view of the results of HPV DNA and high proportion of p16INK4a overexpression, infection by HPV is most likely to be a necessary cause for anal cancers in both men and women.
Journal ArticleDOI
p16 overexpression identifies HPV-positive vulvar squamous cell carcinomas.
Mónica Santos,Stefania Landolfi,Anna Olivella,Belen Lloveras,Joellen Klaustermeier,Helena Suárez,Llucia Alos,Lluís M Puig-Tintoré,Elias Campo,Jaume Ordi +9 more
TL;DR: Immunostaining for p16 is a reliable marker for HPV-positive VSSCs, which improves the results of histologic classification, and the current morphologic criteria to discriminate HPV- positive and negative VSCCs have a significant overlap.
Journal ArticleDOI
HPV prevalence and genotypes in different histological subtypes of cervical adenocarcinoma, a worldwide analysis of 760 cases
Edyta C. Pirog,Belen Lloveras,Anco Molijn,Sara Tous,Núria Guimerà,Maria Alejo,Omar Clavero,Joellen Klaustermeier,David G. Jenkins,Wim Quint,Francesc Bosch,Laia Alemany,Silvia de Sanjosé +12 more
TL;DR: The results indicate that HPV vaccines may prevent up to 82.5% (HPV16/18) and up to 95.3% (9-valent vaccine) of HPV-positive cervical adenocarcinomas, mostly the classic type.
Journal ArticleDOI
Large contribution of human papillomavirus in vaginal neoplastic lesions: a worldwide study in 597 samples.
Laia Alemany,Maëlle Saunier,Leopoldo Tinoco,Beatriz Quirós,Isabel Alvarado-Cabrero,Maria Alejo,Elmar A. Joura,P. Maldonado,Joellen Klaustermeier,Jorge Salmerón,Christine Bergeron,Karl Ulrich Petry,Núria Guimerà,Omar Clavero,Raúl Murillo,Christine Clavel,V. Wain,D.T. Geraets,Robert Jach,P. Cross,Carla Carrilho,Carla Molina,Hai-Rim Shin,Václav Mandys,Andrzej Nowakowski,August Vidal,Luis Estuardo Lombardi,Henry C Kitchener,A.R. Sica,C. Magaña-León,Michael Pawlita,W. G. V. Quint,Ignacio G. Bravo,N Muñoz,S de Sanjosé,Franz X. Bosch +35 more
TL;DR: HPV was identified in a large proportion of invasive vaginal cancers and in almost all VAIN 2/3 and the most common type detected, HPV16 was the most frequently type detected in both precancerous and cancerous lesions.
Journal ArticleDOI
The basaloid cell is the best tissue marker for human papillomavirus in invasive penile squamous cell carcinoma: a study of 202 cases from Paraguay.
Antonio L. Cubilla,Belen Lloveras,Maria Alejo,Omar Clavero,Alcides Chaux,Elena Kasamatsu,Elsa F. Velazquez,Cecilia Lezcano,Núria Monfulleda,Sara Tous,Laia Alemany,Joellen Klaustermeier,Nubia Muñoz,Wim Quint,Silvia de Sanjosé,F. X. Bosch +15 more
TL;DR: HPV was found in a third of the cases and the most common genotype was HPV-16 and the results suggest that, in penile SCC, the basaloid cell is the best tissue marker for oncogenic HPV infection.